C21H16ClF3N4O3.C7H8SO3
A multi kinase inhibitor, anticancer drug
C23H21Cl2FN4O3
A new oral cancer cell inhibitor is used for the treatment of NSCLC, breast cancer and gastric cancer, and has a targeted tyrosine kinase small molecule inhibitor.
C29H26ClFN4O4S.2(C7H8O3S)
An effective inhibitor of EGFR and erbB2.
C13H19NO4S
A chemically synthesized sulfonamide anti gout drug, which is used for chronic gout and inhibiting the excretion of penicillin drugs to improve its plasma concentration. It is used as an auxiliary drug for penicillin treatment.
C21H19ClN4O4.CH4O3S
A multi-target tyrosine kinase inhibitor that may act on a variety of cancers
C23H26FN6O9P.6(H2O).2Na
A spleen tyrosine kinase inhibitor prodrug for the treatment of inflammatory diseases.
C24H25ClFN5O2
A selective and irreversible inhibitor of EGFR. It is a drug candidate for the treatment of non-small cell lung carcinoma.
C24H25ClFN5O3
A kind of irreversible pan-erbB tyrosine kinase inhibitor used to treat cancer.
C24H27Cl3FN5O3
A potent inhibitor of EGFR and ErbB2. It is used for the treatment of recurrent and metastatic breast cancer, ovarian cancer, cervical cancer and many other tumors.
C23H25ClFN5O3
AZD8931 is a novel potent reversible small molecule epidermal growth factor receptor, ERBB2 (HER2) and ERBB3 inhibitor
C23H25ClFN5O3.2(C4H4O4)
A novel potent reversible small molecule epidermal growth factor receptor, ERBB2 (HER2) and ERBB3 inhibitor
C21H15ClF4N4O3.HCl
A multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf.
C23H26FN6O9P
Precursor drug of active metabolite R406 is a Syk inhibitor
C16H17N7O2S
An oral inhibitor of JAK kinases 1 and 2, commonly used in adults for moderate to severe active rheumatoid arthritis (RA).
CHINESE
ENGLISH
Skype Chat
Mail inquiry